Syndax Pharmaceuticals won the first FDA approval last week in a new class of medicines called menin inhibitors. The treatment, Rejuforj, will be available as soon as this month for patients with an ...
Edward White, an analyst from H.C. Wainwright, reiterated the Buy rating on Syndax Pharmaceuticals (SNDX – Research Report). The associated ...
BTIG analyst Justin Zelin has reiterated their bullish stance on SNDX stock, giving a Buy rating on November 15.Don't Miss our Black Friday ...
Explore this weekend's OTT releases across Malayalam, Tamil, and Telugu. Thrillers, action, and dramas, including Kishkindha ...
I just threw in that little trick you told me, laughing like a mad man. You promised 1000 euros and got votes. I promised ...
Karnataka is witnessing a direct contest between the ruling Bharatiya Janata Party (BJP) and Congress. However, the Janata Dal - Secular (JD-S) is eyeing the kingmakers status. Among the top ...
Bitcoin appeared poised to make another run at $70,000, but a WSJ story of a criminal probe into the stablecoin issuer sent prices tumbling Friday afternoon.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback